A 53‐year‐old woman, treated with 10 mg of thiamazole for postoperative recurrence of hyperthyroidism, was referred to our department for further investigation of a neck goiter. The patient's thyroid function was free T3: 2.64 pg/mL (normal range: 2.30‐4.00 pg/mL), free T4: 0.80 ng/dL (0.97‐1.69 ng/dL), and TSH: 3.73 U/mL (0.33‐4.05 U/mL). TSH receptor antibodies (TRAb) were negative. However, the serum thyroglobulin level was elevated to 982 ng/mL (normal range: <33.7 ng/mL). Echocardiography revealed bilateral isoechoic nodules surrounded by low‐echoic lesions. Tc‐99m scintigraphy showed a hot nodule in the left lobe that was consistent with a functional nodule, in addition to a cold nodule in the right lobe (Figure 1A). Pathological examination after subtotal thyroidectomy revealed a right papillary carcinoma (Figure 1B) and a left adenomatous nodule (Figure 1C).
1 FIGURE. Tc‐99m scintigraphy showed both a hot nodule and a cold nodule (A). The right cold nodule was pathologically diagnosed as papillary cancer (B), and the left hot nodule was diagnosed as an adenomatous goiter (C)
Toxic multinodular goiter (TMNG) refers to typically benign nodules in the thyroid gland that autonomously secrete excessive amounts of thyroid hormones, and it is one of the primary causes of hyperthyroidism or thyrotoxicosis. Up to 15% of patients with nodules have neoplastic changes.1 TMNG may be characterized by a mixture of functional and nonfunctional adenomas. A radionuclide scan is useful for identifying the functional status of these nodules. Hot nodules are hyperfunctioning nodules, while cold nodules indicate defects in secretory function. Coincidental carcinomas with TMNG have been rarely reported; whereas a recent study revealed that hot and cold nodules have the same risk of malignancy.2 Therefore, diagnosis should not be based solely on radionuclide images. Physicians should recognize that the most suitable treatment for MTNG is surgical excursion and consider the possibility of malignancy by comprehensive evaluation of imaging studies.
The authors declare no conflicts of interest in association with this study.
YO: contributed to the clinical management of the patients, wrote the first draft, and managed all the submission process. YN, DO, TI, RH, and FO: contributed to the clinical management of the patient and revised the manuscript.
The data regarding this case report are only available from the corresponding author upon reasonable request by considering the protection of patient's privacy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Physicians should be aware of the risk of malignancy in patients with toxic multinodular goiter. Radionuclide scan cannot be used to predict the malignant potential of thyroid nodules. A comprehensive evaluation of imaging studies is needed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
2 Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan
3 Department of Internal Medicine, Kosei General Hospital, Mihara, Japan